Aseem Z. Ansari - 01 Dec 2023 Form 4 Insider Report for Design Therapeutics, Inc. (DSGN)

Role
10%+ Owner
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
Issuer symbol
DSGN
Transactions as of
01 Dec 2023
Net transactions value
$0
Form type
4
Filing time
05 Dec 2023, 18:57:52 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DSGN Stock Option (right to buy) Award $0 +100,000 $0.000000 100,000 01 Dec 2023 Common Stock 100,000 $2.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest as follows: 25% of the shares will vest on October 1, 2024 and the balance will vest in equal monthly installments thereafter over a three year period.